Kiraz, H. A.Toman, H.Erbas, M.Karabulut, Yuyucu Y.Simsek, T.Hanci, VUzun, M.2025-01-272025-01-2720160006-92481336-0345https://doi.org/10.4149/BLL_2016_058https://hdl.handle.net/20.500.12428/24405PURPOSE: Intra-arterial injection of medications are related to mortality and morbidity. It was aimed to investigate the histopathological effects caused by two different intra-arterial doses of sugammadex, a new selective relaxant binding agent used to reverse the effects of steroidal systemic muscle relaxants used in surgeries carried out under general anesthesia. METHODS: A total of 15 rabbits were randomly divided into 3 groups. The control group was given 1 mL saline bolus into the central artery of the ear. The other two groups (Group Sgdx2 and group Sgdx16) were given 2 and 16 mg/kg sugammadex, respectively, intra-arterially. RESULTS: In control group, histopathological evaluation was in normal limits. The cross-sections belonging to Group Sgdx2 did not have any significant pathological change compared with control group (p > 0.05). Edema and single-cell necrosis were significantly higher in Group Sgdx16 when compared to control group (p < 0.05). In comparison to Group Sgdx2, single-cell necrosis was significantly higher in Group Sgdx16 (p < 0.05). CONCLUSION: Being broadly used in anesthesia, sugammadex should be administered with care because when given by intra-arterial route it may cause tissue damage and tissue loss and the patients' arteries should be carefully checked (Tab. 2, Fig. 3, Ref. 21). Text in PDF www.elis.sk.eninfo:eu-repo/semantics/openAccessdoseexperimentalintra-arterialrabbitsugammadexArticle117529529810.4149/BLL_2016_058Q3WOS:0003768133000102-s2.0-8501487333327215966Q2